MultiGen® 2 radiofrequency generator and Venom® cannula and electrode system

MultiGen 2 RF generator and Venom electrode system designed for fast, minimally invasive lesioning
X

MultiGen® 2 radiofrequency generator and Venom® cannula and electrode system | Stryker

The power of a platform

Together, the MultiGen 2 RF generator and Venom cannula and electrode system delivers large, minimally invasive lesions. Made for reliability, efficiency and ultimate control and customization, our Performance Platform delivers an advantage for you and your patients.

Product highlights


MultiGen 2 radiofrequency generator is made for reliability, efficiency and ultimate control and customization

Designed for confidence

Engineered with 100 watts, the MultiGen 2 RF generator can achieve target temperatures fast, maximizing your time. Experience high levels of quality and durability, plus peace of mind with overnight replacement program from ProCare Services.

Customized to you

Create a strip lesion for the SI joint without removing electrodes. Get error solutions that reduce downtime. The MultiGen 2 RF generator is appointed with modern features, like an ultra-responsive touchscreen, a USB port for saving and transferring presets and a lifecycle tracker for electrode use.

Take control

Choose the order of lesions with independently run channels. Perform at your own pace with flexible stimulation controls. With the MultiGen 2 RF generator, you can customize your procedure based on patient needs, procedural goals and personal preferences.

“The MultiGen 2 radiofrequency generator ramps up to temperature quickly and has an outstanding user interface. I can troubleshoot with a simple button without ever shutting down.”
 
Aaron Calodney, MD, Past President of the American Society of Interventional Pain Physicians (ASIPP)*

 

Venom®

cannula and electrode system

Venom radiofrequency cannula optimized for a larger, more consistent lesion

The Venom advantage

The Venom cannula and electrode system offers an alternative configuration at the distal end with a ‘V’ shape active tip, while maintaining the same gauge cannula as the standard configuration.

Venom cannula and electrode system featuring a V-shaped active tip for radiofrequency ablation

Why Venom?

  • Optimized configuration to target lesion zones yielding a larger, more consistent lesion than standard RF cannulae1
  • Ability to perform monopolar and parallel bipolar lesions1
  • Same exceptional quality as Stryker's standard RF cannulae and electrodes1

Product highlights


The 20-gauge Venom cannula creates a larger lesion compared to the standard configuration

Large lesion, small footprint

The 20-gauge Venom cannula creates a 92% larger lesion compared to the standard configuration.1

Industry-leading reliability

Probes are validated for a minimum of 520 sterilization cycles.1

Efficient anesthesia delivery

Cannula side port facilitates immediate propagation of fluid more local to the exposed tip. This may provide more efficient delivery of anesthesia to a targeted lesion zone.1


MultiGen 2 radiofrequency generator heats a variety of cannulae and electrodes

Standard cannula and electrodes

Cannulae

  • Choose straight or curved in a variety of lengths and gauges 
    • Lengths: 50mm, 100mm, 150mm and 200mm 
    • Gauges: 18g, 20g and 22g 
    • Active tips from 5mm to 15mm

Nitinol electrodes

  • Available in color-coded lengths: 50mm, 100mm, 150mm and 200mm 
  • Validated for 520 sterilization cycles1

Interested in learning more?
Contact us.

Pain is unrelenting. But so are we.

Thank you for your interest in Stryker's Interventional Spine products—bold and innovative approaches for treating patients experiencing pain. Tell us how we can help by answering the following questions, and we’ll work to get you what you need.

To place an order, contact your Stryker's Sales Representative or Stryker's Customer Service at 1 800 253 3210.

Thank you!

Be in the know

Engage with us LinkedIn and Instagram to find information about upcoming MedEd events, including webinars, and to be among the first to receive news on technology enhancements, new clinical data and more.